BioCentury
ARTICLE | Distillery Therapeutics

Neurology

September 19, 2017 7:20 PM UTC

Mouse studies suggest inhibiting GABRA1 could help treat schizophrenia. In a mouse model of schizophrenia, injection into the nucleus accumbens (NAC) core of an adeno-associated viral (AAV) vector enc...